These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1363271)

  • 1. Beta-blockers, calcium channel blockers and the sulfhydryl-ACE inhibitors demonstrate protection against free-radical-mediated injury of cardiovascular cells and membranes.
    Weglicki WB; Mak IT; Dickens BF; Kramer JH
    Rev Port Cardiol; 1992 Nov; 11(11):1009-11. PubMed ID: 1363271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The protection of myocardial ischemia--reperfusion injury].
    Miura M; Fujiwara Y
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():667-74. PubMed ID: 12735048
    [No Abstract]   [Full Text] [Related]  

  • 3. The values of detection of free radical mediated reactions in patients.
    Czopf L; Nemes J; Varga J; Lantos J; Röth E
    Acta Chir Hung; 1997; 36(1-4):65-6. PubMed ID: 9408290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Possible significance of free oxygen radicals for reperfusion injury].
    Becker BF; Massoudy P; Permanetter B; Raschke P; Zahler S
    Z Kardiol; 1993; 82 Suppl 5():49-58. PubMed ID: 8154162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study.
    Rejnmark L; Vestergaard P; Mosekilde L
    J Hypertens; 2006 Mar; 24(3):581-9. PubMed ID: 16467662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac medical therapy in patients after undergoing coronary artery bypass graft surgery: a review of randomized controlled trials.
    Okrainec K; Platt R; Pilote L; Eisenberg MJ
    J Am Coll Cardiol; 2005 Jan; 45(2):177-84. PubMed ID: 15653013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Myocardial protection: a look to the future].
    Agati L; Penco M; Dagianti A
    Cardiologia; 1993 Dec; 38(12 Suppl 1):101-9. PubMed ID: 7912649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardioprotection with drugs. 1: Coronary heart disease].
    Michel D
    Fortschr Med; 1990 Jan; 108(3):40-4. PubMed ID: 1968878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of patients who have suffered an acute myocardial infarction in a tertiary care centre.
    Haddad H; Searles G; Gillis A
    Can J Cardiol; 2001 Feb; 17(2):179-83. PubMed ID: 11223488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs].
    Noll G; Kaufmann U; Wenzel RR; Lüscher TF
    Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein (CRP)-lowering agents.
    Prasad K
    Cardiovasc Drug Rev; 2006; 24(1):33-50. PubMed ID: 16939632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug therapy for hypertension in hemodialysis patients.
    Hörl MP; Tepel M
    Minerva Med; 2005 Aug; 96(4):277-85. PubMed ID: 16179894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of calcium channel blockers and angiotensin-converting enzyme inhibitors after cardiac transplantation.
    Rockx MA; Haddad H
    Curr Opin Cardiol; 2007 Mar; 22(2):128-32. PubMed ID: 17284992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Class effect of angiotensin-converting enzyme inhibitors on prevention of myocardial infarction.
    Sauer WH; Baer JT; Berlin JA; Kimmel SE
    Am J Cardiol; 2004 Nov; 94(9):1171-3. PubMed ID: 15518614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of angiotensin II action protects rat steatotic livers against ischemia-reperfusion injury.
    Casillas-Ramirez A; Amine-Zaouali M; Massip-Salcedo M; Padrissa-Altés S; Bintanel-Morcillo M; Ramalho F; Serafín A; Rimola A; Arroyo V; Rodés J; Roselló-Catafau J; Peralta C
    Crit Care Med; 2008 Apr; 36(4):1256-66. PubMed ID: 18379253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive drugs and airway function, with special reference to calcium channel blockade.
    Löfdahl CG
    J Cardiovasc Pharmacol; 1989; 14 Suppl 10():S40-51; discussion S59-62. PubMed ID: 2483571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drugs used in cardiovascular diseases and cytokines].
    Andrzejczak D; Górska D
    Wiad Lek; 2006; 59(3-4):232-7. PubMed ID: 16813270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does reversal of oxidative stress and inflammation provide vascular protection?
    Koh KK; Oh PC; Quon MJ
    Cardiovasc Res; 2009 Mar; 81(4):649-59. PubMed ID: 19098298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Trends in pharmacological treatment of congestive heart failure].
    Halawa B
    Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy in patients with stable coronary artery disease treated on an outpatient basis in Poland. Results of the multicentre RECENT study.
    Banasiak W; Wilkins A; Pociupany R; Ponikowski P
    Kardiol Pol; 2008 Jun; 66(6):642-9; discussion 650. PubMed ID: 18626833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.